TILVX
Price
$27.59
Change
-$0.20 (-0.72%)
Updated
Nov 12 closing price
VIVAX
Price
$69.35
Change
-$0.54 (-0.77%)
Updated
Nov 12 closing price
Ad is loading...

TILVX vs VIVAX

Header iconTILVX vs VIVAX Comparison
Open Charts TILVX vs VIVAXBanner chart's image
Nuveen Large Cap Value Idx R6
Price$27.59
Change-$0.20 (-0.72%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.35
Change-$0.54 (-0.77%)
VolumeN/A
CapitalizationN/A
TILVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TILVX vs. VIVAX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TILVX is a Buy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. TILVX (11.3B). VIVAX pays higher dividends than TILVX: VIVAX (2.25) vs TILVX (2.07). TILVX was incepted earlier than VIVAX: TILVX (22 years) vs VIVAX (32 years). TILVX is a more actively managed with annual turnover of: 21.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than TILVX: VIVAX (3000) vs TILVX (10000000). VIVAX (29.30) and TILVX (29.01) have marching annual gain over last year. VIVAX return over 5 years is better than : 53.44 vs. TILVX (44.92).
TILVXVIVAXTILVX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years32 years-
Gain YTD19.74818.993104%
Front LoadN/AN/A-
Min. Initial Investment100000003000333,333%
Min. Initial Investment IRAN/AN/A-
Net Assets11.3B184B6%
Annual Yield % from dividends2.072.2592%
Returns for 1 year29.0129.3099%
Returns for 3 years14.4622.5264%
Returns for 5 years44.9253.4484%
Returns for 10 years68.90113.8261%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXPL1.150.05
+4.55%
NextPlat Corp
TRUP53.751.34
+2.56%
Trupanion
CRNT2.550.02
+0.79%
Ceragon Networks Ltd
FICO2348.10-1.90
-0.08%
Fair Isaac Corp
DNLI29.90-1.68
-5.32%
Denali Therapeutics